A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL reduces the chance that anal cancer will develop by more than half. Results from the Anal Cancer/HSIL Outcomes Research (ANCHOR) study were published in the New England Journal of Medicine. The trial...